- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02950545
Evaluating and Improving Functional Driving Vision of Patients With Astigmatism: Phase 3
October 4, 2021 updated by: Daniel Cox, PhD, University of Virginia
It is a common clinical practice to leave small amounts of astigmatism uncorrected in contact lens wearers.
Therefore, some drivers who have astigmatism and wear contact lenses may experience blur while driving.
The purpose of this study is to determine if correcting small amounts of astigmatism with contact lenses will improve driving safety.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The purpose of this randomized control trial is to compare visual performance and simulated driving performance of adults with astigmatism when wearing 1*DAY ACUVUE® MOIST for ASTIGMATISM (toric), 1*DAY ACUVUE® MOIST (spherical control), and 1*DAY ACUVUE® MOIST (placebo) contact lenses.
Adult subjects with nearsightedness and astigmatism will wear three types of soft contact lenses (placebo, spherical and toric in randomized order).
Each subject will read letters on standard eye charts and complete vision and driving tests in a driving simulator.
Subjects will repeat these tests with each lens type.
Analyses will include an ANOVA to look for a main effect of lens condition, and separate contrasts to compare toric vs. spherical, toric vs. placebo, and spherical vs. placebo lenses.
Investigating the lenses under simulated driving conditions, which involve eye movement demands, will lend insight into the potential advantages of toric over spherical contact lenses for driving safety.
Study Type
Interventional
Enrollment (Actual)
51
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Virginia
-
Charlottesville, Virginia, United States, 22908
- University of Virginia Driving Safety Laboratory
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 39 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Adult licensed driver
- Ages 18-39 years
- Corrected vision of 20/40 or better in each eye
- Astigmatism between 0.75 and 1.75 diopters in each eye
- Nearsightedness between 0 and -9 diopters in each eye
- No active eye infection
- No defective peripheral vision
- No bifocal correction
- Routinely wears toric contact lenses (more than 4 times per week)
- Routinely drives a car (more than 4 times per week)
- No history of motion, sea, or big screen (e.g. IMAX) sickness, and no persistent Simulation Adaptation Syndrome
Exclusion Criteria:
- Corrected vision worse than 20/40 in either eye
- No astigmatism in either eye
- Active eye infection
- Defective peripheral vision
- Wears bifocals
- Wears contact lenses less than 4 times per week
- Drives infrequently (less than 4 times per week)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Placebo, Spherical, then Toric Lenses
Crossover order 1
|
AcuVue Oasys Bandage Lenses with no prescription
1-DAY ACUVUE® MOIST contact lenses
1-DAY ACUVUE® MOIST for ASTIGMATISM contact lenses
|
Experimental: Placebo, Toric, then Spherical Lenses
Crossover order 2
|
AcuVue Oasys Bandage Lenses with no prescription
1-DAY ACUVUE® MOIST contact lenses
1-DAY ACUVUE® MOIST for ASTIGMATISM contact lenses
|
Experimental: Spherical, Placebo, then Toric Lenses
Crossover order 3
|
AcuVue Oasys Bandage Lenses with no prescription
1-DAY ACUVUE® MOIST contact lenses
1-DAY ACUVUE® MOIST for ASTIGMATISM contact lenses
|
Experimental: Spherical, Toric, then Placebo Lenses
Crossover order 4
|
AcuVue Oasys Bandage Lenses with no prescription
1-DAY ACUVUE® MOIST contact lenses
1-DAY ACUVUE® MOIST for ASTIGMATISM contact lenses
|
Experimental: Toric, Placebo, then Spherical Lenses
Crossover order 5
|
AcuVue Oasys Bandage Lenses with no prescription
1-DAY ACUVUE® MOIST contact lenses
1-DAY ACUVUE® MOIST for ASTIGMATISM contact lenses
|
Experimental: Toric, Spherical, then Placebo Lenses
Crossover order 6
|
AcuVue Oasys Bandage Lenses with no prescription
1-DAY ACUVUE® MOIST contact lenses
1-DAY ACUVUE® MOIST for ASTIGMATISM contact lenses
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Tactical Composite Score
Time Frame: 1 day
|
This scale measures driving performance in the simulator.
It is the sum of the z scores from 15 different driving simulator variables related to braking, steering, speed control and judgment.
The scale has no fixed limits.
A score of 0 indicates average performance.
Higher scores indicate better performance.
|
1 day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Operational Composite Score
Time Frame: 1 day
|
This scale measures driving-relevant visual performance.
It is the sum of the z scores from 5 different driving simulator variables related to visual testing done in the simulator.
The scale has no fixed limits.
A score of 0 indicates average performance.
Higher scores indicate better performance.
|
1 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Daniel J Cox, PhD, University of Virginia
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2016
Primary Completion (Actual)
February 1, 2017
Study Completion (Actual)
February 1, 2017
Study Registration Dates
First Submitted
October 28, 2016
First Submitted That Met QC Criteria
October 28, 2016
First Posted (Estimate)
November 1, 2016
Study Record Updates
Last Update Posted (Actual)
October 6, 2021
Last Update Submitted That Met QC Criteria
October 4, 2021
Last Verified
October 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 18499
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Yes
IPD Plan Description
Data and protocol will be shared on request.
IPD Sharing Time Frame
Data will be available on request
IPD Sharing Access Criteria
data will be shared via e-mail.
IPD Sharing Supporting Information Type
- Study Protocol
- Statistical Analysis Plan (SAP)
- Informed Consent Form (ICF)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Astigmatism
-
Ziemer Ophthalmic Systems AGTigermed Consulting Co., LtdRecruitingMyopic AstigmatismChina
-
Bausch & Lomb IncorporatedCompleted
-
Staar Surgical CompanyActive, not recruiting
-
Coopervision, Inc.CompletedAstigmatism BilateralCanada
-
University Clinic FrankfurtCompleted
-
Ohio State UniversityActive, not recruitingAstigmatism BilateralUnited States
-
Coopervision, Inc.Completed
-
Cairo UniversityUnknown
-
Assiut UniversityCompleted
-
Ashford and St. Peter's Hospitals NHS TrustBausch & Lomb IncorporatedUnknown
Clinical Trials on Placebo Lenses
-
Kaiser PermanenteNot yet recruitingMigraine | Headache | Photophobia
-
Aller, Thomas A., ODJohnson & Johnson Vision Care, Inc.CompletedMyopia | Esophoria | Fixation Disparity
-
University of the Incarnate WordNational Eye Institute (NEI)CompletedColor Vision Defects | Color Blindness | Color Blindness, Red | Color Blindness, GreenUnited States
-
University of North Carolina, Chapel HillCompleted
-
Cornea and Laser Eye InstituteRecruitingKeratoconus | Corneal Ectasia | Irregular Astigmatism | Aberration, Corneal Wavefront | Wavefront Aberration, Corneal | Pellucid Marginal Corneal Degeneration | KeratoglobusUnited States
-
Coopervision, Inc.Recruiting
-
Coopervision, Inc.CompletedPresbyopiaUnited States
-
National Taiwan University HospitalUnknownKeratoconus | Ocular Surface Disease | Irregular AstigmatismTaiwan
-
The Chicago LighthouseUniversity of Illinois at Chicago; Ophthonix IncUnknown
-
University of BradfordCoopervision, Inc.; University of HuddersfieldNot yet recruiting